Logiscreen

Astrazeneca plc

$185.95
Market Cap 288.39B
ROE 22.3%
Gross Margin 82.5%
Debt/Equity 0.7
Current Ratio 0.9
Revenue QoQ 12.5%
EPS QoQ 0.1%
F-Score 5

About

AstraZeneca (LSE/STO/Nasdaq: AZN ) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on social media @AstraZeneca.

Exchange
NYSE
Sector
Healthcare
Industry
Drug Manufacturers - General

Sector context

Healthcare

Fair Value

Trading at a discount to sector peers

P/E
27.14
vs median 33.61
P/B
5.96
vs median 2.16
ROE
0.22
vs median 0.09

Decent quality with acceptable fundamentals

Large-cap company with established market presence

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics